Skip to main content
    T

    Tectonic Therapeutic, Inc. (TECX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $20.98
    -0.16 (-0.76%)

    Market Cap: $413.27M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Tectonic Therapeutic, Inc. (TECX) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Tectonic Therapeutic (TECX) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Tectonic Therapeutic reported EPS of -$1.08, above the -$1.38 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    47%(14/30)
    Avg Surprise
    -11.16%
    Streak
    2 Q

    Upcoming Estimates

    Reports Feb 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$1.42
    Range-$2.00 - -$0.92
    11 analysts
    Revenue Consensus
    N/A
    RangeN/A
    10 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$1.30
    Range-$1.55 - -$0.86
    5 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$1.34+3.3%
    60d ago-$1.34+3.3%
    30d ago-$1.34+3.3%
    7d ago-$1.34+3.3%
    Current-$1.30
    Revenue Consensus
    N/A
    RangeN/A
    6 analysts

    Next Report

    TECX has an expected report date of Feb 24, 2027.

    Earnings History

    Of the 30 quarters below that had an estimate, TECX beat 14 and missed 16. The widest gap in the table came in the quarter ended Mar 31, 2024, when EPS landed 400.00% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$1.08-$1.38N/A+21.74%BeatN/A10 up, 0 downNov 5, 2026
    Jun 30, 2026-$1.18-$1.41-$1.47 - -$1.25+16.31%BeatN/A80 up, 7 downAug 6, 2026
    Mar 31, 2026-$1.34-$1.17-$1.34 - -$1.05-14.53%MissN/A84 up, 0 downMay 7, 2026
    Dec 31, 2025-$1.03-$1.11-$1.21 - -$0.97+7.21%BeatN/A70 up, 1 downFeb 26, 2026
    Sep 30, 2025-$1.02-$1.05-$1.15 - -$0.96+2.86%BeatN/A62 up, 1 downNov 6, 2025
    Jun 30, 2025-$1.07-$0.98N/A-9.18%MissN/AN/A0 up, 0 downAug 7, 2025
    Mar 31, 2025-$0.93-$1.09N/A+14.68%BeatN/AN/A0 up, 0 downMay 8, 2025
    Dec 31, 2024-$0.84-$1.39N/A+39.68%BeatN/A20 up, 0 downMar 20, 2025
    Sep 30, 2024-$1.20-$0.84-$0.95 - -$0.70-42.86%MissN/A20 up, 0 downNov 7, 2024
    Jun 30, 2024-$4.34-$1.30N/A-233.85%Miss-385.5%N/AN/AAug 14, 2024
    Mar 31, 2024-$1.80-$0.36N/A-400.00%MissN/AN/AN/AMay 9, 2024
    Dec 31, 2023-$0.50-$0.43N/A-16.28%MissN/AN/AN/AMar 14, 2024
    Sep 30, 2023-$0.48-$0.36N/A-35.21%MissN/AN/AN/ANov 9, 2023
    Jun 30, 2023$1.52-$0.54N/A+381.01%BeatN/AN/AN/ASep 28, 2023
    Mar 31, 2023-$0.57-$0.55N/A-3.64%MissN/AN/AN/AJun 28, 2023
    Dec 31, 2022-$0.57-$0.49N/A-15.64%MissN/AN/AN/AMar 29, 2023
    Sep 30, 2022-$0.52-$0.55N/A+5.45%BeatN/AN/AN/ANov 8, 2022
    Jun 30, 2022-$0.64-$0.57N/A-11.85%MissN/AN/AN/ASep 28, 2022
    Mar 31, 2022-$0.68-$0.58N/A-16.88%MissN/AN/AN/AJun 28, 2022
    Dec 31, 2021-$0.65-$0.74N/A+12.10%BeatN/AN/AN/AMar 29, 2022
    Sep 30, 2021-$0.75-$0.76N/A+1.04%BeatN/AN/AN/ADec 29, 2021
    Jun 30, 2021-$0.74-$0.66N/A-11.78%MissN/AN/AN/ASep 28, 2021
    Mar 31, 2021-$0.65-$0.75N/A+13.77%BeatN/AN/AN/AJun 29, 2021
    Dec 31, 2020-$0.73-$0.89N/A+17.75%BeatN/AN/AN/AMar 30, 2021
    Sep 30, 2020-$1.01-$0.80N/A-26.71%MissN/AN/AN/ANov 5, 2020
    Jun 30, 2020-$0.80-$0.76N/A-5.26%MissN/AN/AN/AAug 6, 2020
    Mar 31, 2020-$0.77-$0.66N/A-16.67%MissN/AN/AN/AJun 29, 2020
    Dec 31, 2019-$0.72-$0.59N/A-22.03%MissN/AN/AN/AMar 30, 2020
    Sep 30, 2019-$0.57-$0.59N/A+3.39%BeatN/AN/AN/ANov 7, 2019
    Jun 30, 2019-$0.67-$0.75N/A+10.67%BeatN/AN/AN/AAug 8, 2019
    Mar 31, 2019-$8.59N/AN/AN/AN/AN/AN/AN/AJun 29, 2019
    Dec 31, 2018-$8.08N/AN/AN/AN/AN/AN/AN/AMar 30, 2019
    Sep 30, 2018-$5.86N/AN/AN/AN/AN/AN/AN/ANov 13, 2018
    Jun 30, 2018-$5.32N/AN/AN/AN/AN/AN/AN/AAug 9, 2018
    Last 34 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$4.05, after -$8.18 the year before. It was -$19.25 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$4.05N/A
    Dec 31, 2024-$8.18N/A
    Dec 31, 2023-$0.03N/A
    Dec 31, 2022-$2.41N/A
    Dec 31, 2021-$2.79N/A
    Dec 31, 2020-$3.31N/A
    Dec 31, 2019-$10.55N/A
    Dec 31, 2018-$19.25N/A

    Frequently Asked Questions About TECX

    When is Tectonic Therapeutic's next earnings date?

    Tectonic Therapeutic's next earnings report is expected for Feb 24, 2027.

    Did TECX beat earnings estimates last quarter?

    Yes. Tectonic Therapeutic reported EPS of -$1.08 for the quarter ended Sep 30, 2026, above the -$1.38 estimate, a 21.74% surprise.

    What EPS do analysts expect from TECX next quarter?

    The consensus EPS estimate for Tectonic Therapeutic for the quarter ending Dec 31, 2026 is -$1.42 from 11 analysts, with estimates from -$2.00 to -$0.92.

    How often does TECX beat earnings estimates?

    Tectonic Therapeutic beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +9.85%.